Eiko Lifescience

Narendra_Invest.26 Apr 2024

Chemicals

₹

-2.07 (-3.72%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Eiko Lifescience

Eiko Lifescience

Chemicals

Narendra_Invest.26 Apr 2024

₹

-2.07 (-3.72%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
05-Apr-2017	D	Outcome of Board Meeting held today at the registered office of the company along with Audited Financial Results for the year ended 31st March' 2017. Board is pleased to declare the maiden dividend @2.50% or 25 paise per equity share of face value of Rs. 10/- each.	20-Sep-2017
30-Jun-2023	R	2:3 Right Issue of Equity Shares Trading Members of the Exchange are hereby informed that EIKO LIFESCIENCES LIMITED has fixed Record Date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE EIKO LIFESCIENCES LIMITED (540204) RECORD DATE 07.07.2023 PURPOSE Issue of 2 (Two) Equity Shares of Rs.10/- each for cash at a premium of Rs.35/- per share on Rights Basis for every 3 (Three) Equity Shares held.* Ex-Right basis from Date & Sett. No. 07/07/2023 DR-566/2023-2024 * Note : As per terms of Payment : Issue Price of Rs.45/- payable as Rs.13.50 per Rights Equity Share (including premium of Rs.10.50) to be paid on Application. Balance to be paid in not more than two calls as determined by our Board at its sole discretion. Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 04.07.2023)	07-Jul-2023	2:3
23-Apr-2024	BC	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Eiko Lifesciences Ltd (Scrip Code: 540204) with effect from Wednesday, Ap	24-Apr-2024
16-Feb-2024	BC	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Eiko Lifesciences Ltd (Scrip Code: 540204) with effect from Monday, Febru	19-Feb-2024
01-Feb-2024	BC	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve This is to inform you that as required un	08-Feb-2024
25-Jan-2024	BC	Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would li	25-Jan-2024
14-Dec-2023	BC	Conversion of Partly Paid up-First and FinalCall of Rs.31.50 This is to inform you that the Meeting of the Right Issue Committee of the Board of Directors of the Company held today i.e., Thursday	22-Dec-2023

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)35

Ratio2:3

Book Closure

Record Date	Split Date	Purpose
24-Apr-2024	-	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Eiko Lifesciences Ltd (Scrip Code: 540204) with effect from Wednesday, Ap
19-Feb-2024	-	Trading Members of the Exchange are hereby informed that they are permitted to trade in the under mentioned new securities of Eiko Lifesciences Ltd (Scrip Code: 540204) with effect from Monday, Febru
08-Feb-2024	-	Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve This is to inform you that as required un
25-Jan-2024	-	Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would li
22-Dec-2023	-	Conversion of Partly Paid up-First and FinalCall of Rs.31.50 This is to inform you that the Meeting of the Right Issue Committee of the Board of Directors of the Company held today i.e., Thursday

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Eiko Lifesciences Ltd ₹53.51(-2.07/-3.72%)	53.51	-2.07	66.46	-24.35	92.26	1.68
BASF India Ltd ₹3,704.40(+85.90/2.37%)	3,704.40	+85.90	16,036.35	58.65	33.90	5.48
Bhagawati Oxygen Ltd ₹49.28(+4.48/10.00%)	49.28	+4.48	11.38	17.03	7.80	1.68
Oriental Aromatics Ltd ₹370.20(-10.95/-2.87%)	370.20	-10.95	1,245.86	-10.12	0.00	2.00
Atul Ltd ₹5,928.75(+50.35/0.86%)	5,928.75	+50.35	17,455.28	-15.82	45.39	3.43
Advance Petrochemicals Ltd ₹203.30(-10.70/-5.00%)	203.30	-10.70	18.30	-53.68	0.00	5.26

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	6.61	6.41	6.51	6.59	4.38	4.31
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	6.61	6.41	6.51	6.59	4.38	4.31
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.01	0.03	0.03	0.21	0.19	0.23
Total Income	6.63	6.44	6.54	6.80	4.56	4.54
Total Expenditure	6.15	6.06	6.23	6.23	4.05	4.17
PBIDT	0.48	0.38	0.30	0.57	0.51	0.37
Interest	0.03	0.06	0.03	0.03	0.01	0.01
PBDT	0.45	0.32	0.27	0.54	0.50	0.36
Depreciation	0.16	0.16	0.16	0.16	0.16	0.16
Tax	0.00	0.00	0.00	0.05	0.00	0.00
Deferred Tax	0.05	0.04	0.03	0.05	0.09	0.05
Reported Profit After Tax	0.24	0.12	0.08	0.28	0.25	0.15
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.24	0.12	0.08	0.28	0.25	0.15

EPS (Unit Curr.)	0.24	0.12	0.10	0.34	0.26	0.18
EPS (Adj) (Unit Curr.)	0.24	0.12	0.09	0.29	0.23	0.16
Calculated EPS (Unit Curr.)	0.24	0.12	0.10	0.34	0.31	0.18
Calculated EPS (Adj) (Unit Curr.)	0.24	0.12	0.09	0.29	0.27	0.16
Calculated EPS (Ann.) (Unit Curr.)	0.95	0.48	0.38	1.36	1.22	0.72
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.95	0.48	0.33	1.18	1.06	0.62
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	9.98	9.98	8.32	8.32	8.32	8.32
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.26	5.93	4.61	8.65	11.64	8.58
PBDTM(%)	6.81	4.99	4.15	8.19	11.42	8.35
PATM(%)	3.63	1.87	1.23	4.25	5.71	3.48

Column	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Gross Sales	0.84	0.56	0.62	3.20	4.22	2.31
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.84	0.56	0.62	3.20	4.22	2.31
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.01	0.05	-0.04	0.01	0.05	0.03
Total Income	0.85	0.61	0.58	3.22	4.27	2.34
Total Expenditure	0.89	0.42	1.54	4.55	6.09	2.73
PBIDT	-0.03	0.18	-0.96	-1.33	-1.82	-0.39
Interest	0.10	0.01	0.03	0.08	0.06	0.07
PBDT	-0.14	0.18	-0.98	-1.42	-1.89	-0.45
Depreciation	0.04	0.04	0.05	0.05	0.05	0.05
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.01	0.01	0.00	0.01	0.01	0.01
Deferred Tax	-0.05	0.03	-0.29	-0.39	-0.51	-0.14
Reported Profit After Tax	-0.13	0.10	-0.74	-1.08	-1.42	-0.37
Minority Interest After NP	-0.08	0.04	-0.33	-0.49	-0.71	-0.19
Net Profit after Minority Interest	-0.05	0.06	-0.41	-0.59	-0.71	-0.19

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.05	0.06	-0.41	-0.59	-0.71	-0.19

EPS (Unit Curr.)	-0.14	0.17	-1.08	-1.55	-1.87	-0.50
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.82	3.82	3.82	3.82	3.82	3.82

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-3.57	32.14	-154.84	-41.56	-43.13	-16.88
PBDTM(%)	-16.67	32.14	-158.06	-44.38	-44.79	-19.48
PATM(%)	-15.48	17.86	-119.35	-33.75	-33.65	-16.02

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	8.32	8.32	3.82	3.82	3.82	3.82
Reserves Total	21.11	20.31	2.37	1.66	1.61	1.73
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	6.34	0.00	0.00	0.00
Total Shareholders Funds	29.43	28.63	12.53	5.48	5.43	5.55
Secured Loans	0.05	0.13	0.20	0.26	0.31	0.37
Unsecured Loans	0.00	4.50	1.63	0.00	0.00	0.00
Total Debt	0.05	4.63	1.83	0.26	0.31	0.37
Total Liabilities	29.48	33.26	14.36	5.74	5.74	5.92
APPLICATION OF FUNDS :
Gross Block	15.34	15.12	0.52	0.52	0.52	0.52
Less : Accumulated Depreciation	1.46	0.83	0.27	0.21	0.14	0.08
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	13.88	14.29	0.25	0.31	0.38	0.44
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	0.20	0.22	0.50	2.13	3.58
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.91	5.46	0.06	0.00	0.00	0.00
Sundry Debtors	7.11	4.56	3.41	0.00	0.08	0.00
Cash and Bank	0.61	0.22	4.07	0.02	0.03	0.73
Loans and Advances	0.67	2.20	3.16	2.14	0.60	0.33
Total Current Assets	9.30	12.44	10.71	2.16	0.71	1.07
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.10	1.40	1.91	0.00	0.01	0.00
Provisions	0.05	0.03	0.35	0.02	0.01	0.01
Total Current Liabilities	1.15	1.43	2.26	0.02	0.02	0.01
Net Current Assets	8.15	11.01	8.44	2.14	0.69	1.06
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.03	0.05	0.02	0.05	0.01	0.01
Deferred Tax Liability	0.45	0.26	0.00	0.00	0.01	0.07
Net Deferred Tax	-0.42	-0.21	0.02	0.05	0.00	-0.06
Total Assets	21.66	25.29	8.93	3.00	3.19	5.01
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.22	4.07	0.02	0.03	0.73
Net Cash from Operating Activities	4.22	-7.73	-0.83	0.77	-0.19
Net Cash Used In Investing Activities	0.87	0.59	-2.94	-0.65	-0.43
Net Cash Used In Financing Activities	-4.70	3.28	7.81	-0.13	-0.08
Net Inc./Dec In Cash And Cash Equivalents	0.40	-3.85	4.05	-0.01	-0.71
Cash And Cash Equivalents At End Of The Year	0.61	0.22	4.07	0.02	0.03

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

24.23%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

75.77%

**Promoter pledged shareholding 24.23%

About Eiko Lifesciences Ltd

Eiko Lifesciences Ltd is in the Chemicals sector, having a market capitalization of Rs. 66.46 crores. It has reported a sales of Rs. 6.61 crores and a net profit of Rs. 0.24 crores for the quarter ended December 2018. The company management includes Laxmikant Kabra, Laxmikant Kabra,Bhavesh Dhirajlal Tanna,Rajkumar K Baheti,Mandkar Kamalakar Patil,Kajal Dhanpatraj Kothari,Umesh Ravindranath More,Chintan Doshi (Eiko Lifesciences Ltd) among others.

Chairman

Laxmikant Kabra

Registered office

1st Matru Chhaya Ground Floor,M Karve Road Naupada,Thane,Maharashtra,400602

FAX :

Background

Incorporation Year1977

Face Value₹10

Market Lot1

How to buy Eiko Lifescience shares on nse?

To buy Eiko Lifescience shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Eiko Lifescience share price today?

The Eiko Lifescience shares price on nse is Rs.53.51 today.

What is the market cap of Eiko Lifescience shares on BSE ?

The company has a market capitalization of Rs.66.46Cr

What is the PE & PB ratio of Eiko Lifescience shares ?

PE is 92.26 and PB is 1.68

What is the 52 Week High and Low of Eiko Lifescience shares?

Eiko Lifescience stock price high: Rs.81.32 Eiko Lifescience stock price low: Rs.46.79